There was a significant increase in the number of NSS performed with time, 9.26% between 1997- 2002 to 54.78% between 2013-2017 (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: Nephron-sparing surgery (NSS) is the first-line treatment for T1N0M0 renal tumors (RT).
📊
Key Findings & Data:The aim of this multicentric retrospective study is to investigate the national trends and the effect of non-tumoral factors in the preference of NSS as treatment of T1 RT in Turkey.
💡
Conclusion & Impact:There was a significant increase in the number of NSS performed with time, 9.26% between 1997- 2002 to 54.78% between 2013-2017 (p
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters
Abstract
Objective: Nephron-sparing surgery (NSS) is the first-line treatment for T1N0M0 renal tumors (RT). The aim of this multicentric retrospective study is to investigate the national trends and the effect of non-tumoral factors in the preference of NSS as treatment of T1 RT in Turkey. Materials and Methods: Relevant data for patients operated between 1997 and 2017 was collected from the Urologic Cancer Database-Kidney Urooncology Association, Turkey (UroCaD-K). Results: We included 3195 T1N0M0 RT patients in this study. There was a significant increase in the number of NSS performed with time, 9.26% between 1997- 2002 to 54.78% between 2013-2017 (p
🔖
Cite This Article
Bozkurt, O., Ataus, S., Baltacı, S., Akdoğan, B., Özden, E., Sözen, S., İzol, V., Bayazıt, Y., Kuzgunbay, B., Yaycıoğlu, Ö., Özkan, T. A., Tınay, İ. (2022). Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey. Üroonkoloji Bülteni, Cilt: 20 - Sayı: 4, 247–251. https://ajindex.com/articles/645733
Ljungberg B, Albiges L, Bensalah K, et al. EAU guidelines on renal cell carcinoma. 2020;1:1-73
Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-552
Arnold ML, Thiel DD, Diehl N, et al. Comparison of baseline quality of life measures between renal cell carcinoma patients undergoing partial versus radical nephrectomy. BMC Urol 2013;13:52
Pierorazio PM, Johnson MH, Patel HD, et al. Management of renal masses and localized renal cancer: systematic review and metaanalysis. J Urol 2016;196:989-999
Huang WC, Elkin EB, Levey AS, et al. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? J Urol 2009;181:55-61; discussion 61-52
Kates M, Badalato GM, Pitman M, et al. Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less. J Urol 2011;186:1247-1253
Weight CJ, Larson BT, Fergany AF, et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 2010;183:1317-1323
Scosyrev E, Messing EM, Sylvester R, et al. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol 2014;65:372-377
Poulakis V, Witzsch U, de Vries R, et al. Quality of life after surgery for localized renal cell carcinoma: comparison between radical nephrectomy and nephron-sparing surgery. Urology 2003;62:814-820
Huang WC, Donin NM, Levey AS, et al. Chronic kidney disease and kidney cancer surgery: new perspectives. J Urol 2020;203:475-485
Dulabon LM, Lowrance WT, Russo P, et al. Trends in renal tumor surgery delivery within the United States. Cancer 2010;116:2316-2321
Patel SG, Penson DF, Pabla B, et al. National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol 2012;187:816-821
Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-381
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: